OptiBiotix Health (LON:OPTI) Insider David Blain Acquires 158,965 Shares

OptiBiotix Health Plc (LON:OPTI) insider David Blain bought 158,965 shares of the stock in a transaction on Thursday, May 28th. The shares were acquired at an average price of GBX 6 per share, with a total value of £9,537.90.

OptiBiotix Health Price Performance

OPTI stock opened at GBX 6.05 on Friday. OptiBiotix Health Plc has a 1-year low of GBX 4.50 and a 1-year high of GBX 15. The firm has a fifty day moving average price of GBX 5.31 and a two-hundred day moving average price of GBX 6.35. The firm has a market cap of £6.25 million, a price-to-earnings ratio of -201.67 and a beta of 1.71.

OptiBiotix Health (LON:OPTI) last released its quarterly earnings results on Thursday, May 28th. The company reported GBX (3.84) EPS for the quarter. The firm had revenue of GBX 117 million for the quarter. OptiBiotix Health had a negative return on equity of 2.27% and a negative net margin of 16.59%.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.